Bionpharma Inc

General

Total Cases24

Active Cases4

Patents1

CourtsD. Delaware D. New Jersey

TypeOperating Company

Elite Ratings

--

Ratings

Experience

Grade

Trend

DCT

L2

B

PTAB

--

--

--

CAFC

--

--

--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
12/23/24	Silvergate Pharmaceuticals Inc v. Bionpharma Inc 1:18-CV-01962 ( D. DE )	USCA Order Terminating Appeal as to [344] Notice of Appeal (Federal Circuit) filed by Bionpharma Inc. USCA Decision: Appeal Dismissed. (jfm) (Entered: 12/23/2024)
12/23/24	Silvergate Pharmaceuticals Inc v. Bionpharma Inc 1:19-CV-01067 ( D. DE )	USCA Order Terminating Appeal as to [329] Notice of Appeal (Federal Circuit) filed by Bionpharma Inc. USCA Decision: Appeal Dismissed. (jfm) (Entered: 12/23/2024)
11/19/24	Silvergate Pharmaceuticals Inc v. Bionpharma Inc 1:18-CV-01962 ( D. DE )	TRANSCRIPT REQUEST by Bionpharma Inc. (Haney, Megan) (Entered: 11/19/2024)
11/19/24	Silvergate Pharmaceuticals Inc v. Bionpharma Inc 1:19-CV-01067 ( D. DE )	TRANSCRIPT REQUEST by Bionpharma Inc. (Haney, Megan) (Entered: 11/19/2024)
11/05/24	Silvergate Pharmaceuticals Inc v. Bionpharma Inc 1:18-CV-01962 ( D. DE )	NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re [344] Notice of Appeal (Federal Circuit) filed by Bionpharma Inc. USCA Case Number 2025-1148 (mpb) (Entered: 11/05/2024)
11/05/24	Silvergate Pharmaceuticals Inc v. Bionpharma Inc 1:19-CV-01067 ( D. DE )	NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re [329] Notice of Appeal (Federal Circuit) filed by Bionpharma Inc. USCA Case Number 2025-1149 (mpb) (Entered: 11/05/2024)
11/01/24	Azurity Pharmaceuticals Inc v. Bionpharma Inc 1:21-CV-01286 ( D. DE )	NOTICE OF SERVICE of Bionpharma's Summary of Its Planned Expert Testimony, Reply Expert Report of R. Christian Moreton, Ph.D. on the Objective Baselessness of Plaintiff Azurity's Patent Infringement Claims in the First, Second and Third Wave Suits, Reply Expert Report of Bret M. Dickey, Ph.D. and Reply Expert Report of Nancy J. Linck, Ph.D. filed by Bionpharma Inc..(Haney, Megan) (Entered: 11/01/2024) NOTICE OF SERVICE of Bionpharma's Summary of Its Planned Expert Testimony, Reply Expert Report of R. Christian Moreton, Ph.D. on the Objective Baselessness of Plaintiff Azurity's Patent Infringement Claims in the First, Second and Third Wave Suits, Reply Expert Report of Bret M. Dickey, Ph.D. and Reply Expert Report of Nancy J. Linck, Ph.D. filed by Bionpharma Inc..(Haney, Megan) (Entered: 11/01/2024)
11/01/24	Azurity Pharmaceuticals Inc v. Bionpharma Inc 1:21-CV-01286 ( D. DE )	ORDER: Defendant's Motion to Strike (D.I. [549] ) is GRANTED IN PART and DENIED IN PART such that, Dr. Mahan's report is STRICKEN, and the Motion is otherwise DENIED without prejudice. (See Order for further details) Signed by Judge Mitchell S. Goldberg on 11/1/2024. (mpb) (Entered: 11/01/2024)
10/31/24	Silvergate Pharmaceuticals Inc v. Bionpharma Inc 1:18-CV-01962 ( D. DE )	NOTICE OF APPEAL to the Federal Circuit of [342] Memorandum Opinion, [343] Order,, Terminate Motions, . Appeal filed by Bionpharma Inc.. (Phillips, John) (Entered: 10/31/2024)
10/31/24	Silvergate Pharmaceuticals Inc v. Bionpharma Inc 1:19-CV-01067 ( D. DE )	NOTICE OF APPEAL to the Federal Circuit of [327] Memorandum Opinion, [328] Order,, Terminate Motions, . Appeal filed by Bionpharma Inc.. (Phillips, John) (Entered: 10/31/2024)